I-Scleroderma ligama lonyango kwisifo esibangela ukuqina nobunzima besikhumba okanye izicubu ezixhumeneyo (iimbumba ezixhasa ulusu kunye nezitho zangaphakathi).
Kukho iintlobo ezimbini eziphambili ze-scleroderma: zendawo kunye neenkqubo. Nangona i-scleroderma yendawo ichaphazela kuphela isikhumba sakho, i-systemic scleroderma ayichaphazeli kuphela isikhumba sakho kodwa kunye nemithambo yakho yegazi kunye nezitho zangaphakathi (njengentliziyo yakho nemiphunga).
IziNyango zeNdalo zeSkleroderma
Kukho ubungqina obuncinci besayensi obuxhasa ukusetyenziswa kweyeza elithile kunyango lwe-scleroderma. Nangona kunjalo, ezi zilandelayo izilungiso zingabanceda abantu abajongayo ukulawula le meko.
1) I-Vitamin D
Kuhlolisiso luka-2009 lwabantu aba-156 abane-systic scleroderma, abaphandi bafumene ukuba ukungakwazi kakuhle kwe-vitamin D kunye nokulahleka kwamazinga kwakuphezulu kakhulu kubantu abaneengxaki. Ababhali beencwadi baqaphele ukuba i-vitamin D eyongezelelweyo yokuncedisa ayibonakali ukulungisa ukungabikho kwezigulane ze-scleroderma kwaye ukuba i-dose ephezulu ifuneka kakhulu kubantu abanjalo.
Ukuba uhlangabezana ne-systemic scleroderma, qhagamshelana nogqirha wakho ukuze ufumane isilinganiselo esifanelekileyo se-vitamin D (isicatshulwa esisondlo sokuncedisa ukulawula umzimba wamasosha omzimba).
2) I-Vitamin E
Ukusetyenziswa kwesicatshulwa se-vitamin E gel kunokunciphisa ixesha lokuphulukisa kunye nokunciphisa intlungu kubantu abanezilonda zedijithali ezibangelwa yi-systemic scleroderma, ngokutsho kwe-2009 yezigulane ezingama-27.
Uphando oludlulileyo lubonisa ukuba i-vitamin E inokuthatha isenzo sokuthi i-antifibrotic ishintshwe kwaye inokunceda ukukhawulela umxube weethambo ezininzi.
Iimpawu zeSkleroderma
I-Morphea (uhlobo olulodwa lwe-scleroderma lwendawo) lubhalwe ngamagqabha enqabileyo, anamaqabunga ekhumba amhlophe phakathi kwaye abe nomda omfusa.
I-scleroderma yomgca (olunye uhlobo lwe-scleroderma yendawo) liphawulwe ngamagqabi okanye kwiintsika zesikhumba esinzima kwiingalo, imilenze okanye ebunzini.
Kubantu abane-systemic scleroderma, iimpawu ziyahluka ngokuxhomekeka kwimeko yomzimba echaphazelekayo yintlupheko.
I-Scleroderma nayo inokuvelisa iimpawu ezilandelayo:
- Izifo zikaRaynaud
- amabala obomvu ezandleni nasebusweni
- isikhumba esiqinileyo, esomeleleyo kwiminwe yakho
- GERD
Yintoni Eyibangela?
Isizathu esona sizathu se-scleroderma asiyazi. Nangona kunjalo, kucingwa ukuba umsebenzi ongaqhelekanga kwindlela yokuzivikela emzimbeni yenza ukuba iiseli zenze i-collagen ibe yinto engaphezulu, nto leyo eyenza izicubu ezidibeneyo zokwakha. Ngenxa yoko, iyaziwa njengesifo sokuzimela, esichaza isifo se-immune system.
Ezinye izinto zinokunyusa ingozi yakho ye-scleroderma. Ezi ziquka:
- ngumfazi
- ukuthungulwa kothuli lwe-silika kunye nezinye izivululwazi zoshishino (ezifana nepeyinti zepende)
- ehamba ngendlela ethile ye-chemotherapy (i-bleomycin)
Ama-Afrika aseMerika kunye namaqela athile aseMerika aseMelika (kuquka iChoctaw yaseMelika yaseMelika) nayo ibonakala ngathi ingozi enkulu ye-scleroderma okanye iingxaki zayo.
Ezinye iindlela zokonyango
Ekubeni i-scleroderma ingakhokelela ekubandezeleni ubomi (njengobungozi obukhulu entliziyweni, emaphaphu, nasezintso), kubalulekile ukufuna unyango xa ubonisa iimpawu zesi sifo.
Nangona ngexesha langoku akukho ndlela yokumisa ukwanda kwe-collagen kunye nokunyanga i-scleroderma, unyango oluthile lunokukunceda ukulawula iimpawu nokunciphisa umonakalo.
Unyango luxhomekeke kwiindawo ezichaphazelekayo kwaye ingaquka ukusetyenziswa kwamachiza, unyango, kunye / okanye unyango lomzimba.
> Imithombo:
> Gaby AR. "Izonyango zemvelo ze-scleroderma." I-Altern Med Rev. 2006 11 (3): 188-95.
> Fiori G, Fiori G, Galluccio F, Braschi F, Amanzi L, Miniati I, Conforti ML, Del Rosso A, Generini S, Candelieri A, Magonio A, Goretti R, Rasero L. "I-vitamin E gel iyanciphisa ixesha lokuphilisa izilonda zedijithali kwi-systemic sclerosis. " Iiklinikhi Exp Rheumatol. 2009 27 (I-Suppl 54): 51-4.
> I-Vacca A, iCormier C, i-Piras M, i-Mathieu A, i-Kahan A, i-Allanore Y. "Ukuntula kwe-Vitamin D kunye nokungazinzi kwi-cohorts ezi-2 ezizimeleyo zezigulane ezine-sclerosis." J Rheumatol. 2009 36 (9): 1924-9.